TP53 and neoplasm: MDM2 is a principal negative regulator of p53, attenuating its tumor suppressor function through dual mechanisms: as an E3 ubiquitin ligase, it targets p53 for proteasomal degradation [79], and it also inhibits p53’s transcriptional activity [80].